Grace-Marie Turner
Contributor
Grace-Marie Turner is president of the Galen Institute.

LATEST
-
opinionGrace-Marie Turner | Nina Owcharenko Schaefer
Medicare Drugs on Chopping Block
The Biden administration is expected to announce, by Sept. 1, the first 10 prescription drugs it will target in its newly authorized drug price “negotiation” regime. Under the Inflation Reduction Act (more properly dubbed the Innovation Reduction Act), the Centers for Medicare and Medicaid Services will announce the 10 drugs under Medicare Part D that…

Don’t miss the

